Equity Transactions (Tables)

12 Months Ended

Jun. 30, 2019

Schedule of estimation of estimated the fair value of the warrants granted

For the year ended June 30, 2017, the Company estimated the fair value of the warrants granted quarterly to the Scientific Advisory Board on the date of grant using the Black-Scholes Option-Pricing Model with the following weighted-average assumptions:


Expected life (year)	4

Expected volatility	55.57% - 87.09	%

Expected annual rate of quarterly dividends	0.00	%

Risk-free rate(s)	1.00 - 1.79	%

For the year ended June 30, 2018, the Company estimated the fair value of the warrants granted quarterly to the Scientific Advisory Board on the date of grant using the Black-Scholes Option-Pricing Model with the following weighted-average assumptions:


Expected life (year)	4

Expected volatility	53.56% - 56.10	%

Expected annual rate of quarterly dividends	0.00	%

Risk-free rate(s)	1.67 - 2.84	%

For the year ended June 30, 2019, the Company estimated the fair value of the warrants granted quarterly to the Scientific Advisory Board on the date of grant using the Black-Scholes Option-Pricing Model with the following weighted-average assumptions:


Expected life (year)	4

Expected volatility	47.46- 55.12	%

Expected annual rate of quarterly dividends	0.00	%

Risk-free rate(s)	2.14- 2.93	%

Schedule of proceeds of the offering

The Company accounted for the proceeds of the Offering at February 27, 2019 as follows:


Gross proceeds	$	2,500,000
Less: Offering costs		150,000
Net proceeds		2,350,000
Portion allocated to derivative liability - warrants		(1,527,259)
Net proceeds from issuance of common stock	$	822,741

Schedule of projected anuual volatility


1 Year
2/27/2019	75	%
6/30/2019	76.1	%

Series B Convertible Debentures [Member]

Schedule of estimation of estimated the fair value of the warrants granted

For the year ended June 30, 2018, the Company estimated the fair value of the warrants granted to Eugene Seymour on the date of grant using the Black-Scholes Option-Pricing Model with the following weighted-average assumptions:


Expected life (year)	5

Expected volatility	53.56	%

Expected annual rate of quarterly dividends	0.00	%

Risk-free rate(s)	2.56

Series A preferred stock [Member]

Schedule of fair value of Series A Preferred Stock

The fair value of the Series A Preferred Stock at each date of issuance was as follows:


Date	Shares	Value
7/31/2016	2,572	$	11,439
8/31/2016	2,572		11,978
9/30/2016	2,572		10,847
10/31/2016	2,572		9,591
11/30/2016	2,572		7,631
12/31/2016	2,572		6,583
1/25/2017	200,000		512,984
1/31/2017	2,572		6,231
2/28/2017	2,572		6,357
3/03/2017	26,786		65,630
3/31/2017	2,572		6,493
4/30/2017	2,572		6,679
5/31/2017	2,572		7,500
6/30/2017	2,572		7,633
	257,650	$	677,576

The fair value of the Series A Preferred stock was the following for the dates indicated:


Date	Shares	Value
7/31/2017	2,572	$	8,242
8/31/2017	2,572		8,397
9/30/2017	2,572		8,588
10/31/2017	2,572		7,011
11/30/2017	2,572		6,313
12/31/2017	2,572		6,513
1/31/2018	2,572		5,552
2/28/2018	2,572		5,404
3/03/2018	26,786		60,725
3/31/2018	2,572		5,811
4/30/2018	2,572		5,215
5/31/2018	2,572		4,639
6/30/2018	2,572		3,696
	57,650	$	136,106

The fair value of the Series A Preferred Stock was the following for the dates indicated:


Date	Shares	Value
7/11/2018	525,000	$	560,690
7/31/2018	2,572		2,795
8/31/2018	2,572		2,374
9/30/2018	2,572		2,598
10/31/2018	2,572		2,233
11/30/2018	2,572		1,883
12/31/2018	2,572		2,245
1/31/2019	2,572		1,203
2/28/2019	2,572		1,949
3/01/2019	26,786		24,340
3/31/2019	2,572		2,336
4/30/2019	2,572		1,636
5/31/2019	2,572		1,540
6/30/2019	2,572		1,696
	582,650	$	609,518